Ad is loading...
KSRBF
Price
$0.27
Change
-$0.00 (-0.00%)
Updated
Oct 9 closing price
NPCE
Price
$8.98
Change
-$0.70 (-7.23%)
Updated
Nov 15 closing price
107 days until earnings call
Ad is loading...

KSRBF vs NPCE

Header iconKSRBF vs NPCE Comparison
Open Charts KSRBF vs NPCEBanner chart's image
Kossan Rubber Industries
Price$0.27
Change-$0.00 (-0.00%)
Volume$200
CapitalizationN/A
Neuropace
Price$8.98
Change-$0.70 (-7.23%)
Volume$115.82K
CapitalizationN/A
KSRBF vs NPCE Comparison Chart
Loading...
NPCE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KSRBF vs. NPCE commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KSRBF is a Hold and NPCE is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (KSRBF: $0.27 vs. NPCE: $8.98)
Brand notoriety: KSRBF and NPCE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: KSRBF: 100% vs. NPCE: 145%
Market capitalization -- KSRBF: $789.51M vs. NPCE: $385.2M
KSRBF [@Medical Specialties] is valued at $789.51M. NPCE’s [@Medical Specialties] market capitalization is $385.2M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KSRBF’s FA Score shows that 2 FA rating(s) are green whileNPCE’s FA Score has 0 green FA rating(s).

  • KSRBF’s FA Score: 2 green, 3 red.
  • NPCE’s FA Score: 0 green, 5 red.
According to our system of comparison, KSRBF is a better buy in the long-term than NPCE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NPCE’s TA Score shows that 5 TA indicator(s) are bullish.

  • NPCE’s TA Score: 5 bullish, 5 bearish.

Price Growth

KSRBF (@Medical Specialties) experienced а 0.00% price change this week, while NPCE (@Medical Specialties) price change was +19.57% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

NPCE is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KSRBF($790M) has a higher market cap than NPCE($385M). KSRBF YTD gains are higher at: 0.000 vs. NPCE (-12.900). KSRBF has higher annual earnings (EBITDA): 144M vs. NPCE (-22.83M). KSRBF has more cash in the bank: 2.03B vs. NPCE (66.5M). KSRBF has less debt than NPCE: KSRBF (43.1M) vs NPCE (72.4M). KSRBF has higher revenues than NPCE: KSRBF (1.85B) vs NPCE (65.4M).
KSRBFNPCEKSRBF / NPCE
Capitalization790M385M205%
EBITDA144M-22.83M-631%
Gain YTD0.000-12.900-
P/E Ratio92.59N/A-
Revenue1.85B65.4M2,832%
Total Cash2.03B66.5M3,057%
Total Debt43.1M72.4M60%
TECHNICAL ANALYSIS
Technical Analysis
NPCE
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
NPCE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMCKX8.960.03
+0.34%
Miller Income FI
PINLX14.07-0.11
-0.78%
Principal Diversified Intl R4
DHTYX26.58-0.25
-0.93%
Diamond Hill Select Y
LMNOX42.47-0.50
-1.16%
Patient Opportunity I
VSQAX18.61-0.24
-1.27%
Invesco MSCI World SRI Index A

KSRBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, KSRBF has been closely correlated with FLMNY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if KSRBF jumps, then FLMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KSRBF
1D Price
Change %
KSRBF100%
N/A
FLMNY - KSRBF
69%
Closely correlated
+0.12%
BDSX - KSRBF
26%
Poorly correlated
-3.93%
EDTXF - KSRBF
22%
Poorly correlated
-0.98%
NPCE - KSRBF
21%
Poorly correlated
-7.23%
IMTH - KSRBF
13%
Poorly correlated
N/A
More

NPCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with FNA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then FNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
-7.23%
FNA - NPCE
36%
Loosely correlated
+3.20%
STVN - NPCE
34%
Loosely correlated
-7.32%
SHC - NPCE
31%
Poorly correlated
-4.54%
IRMD - NPCE
28%
Poorly correlated
-3.56%
OM - NPCE
27%
Poorly correlated
-8.01%
More